Actinogen Medical Limited
ATGGF
$0.03
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | 0.31% | -65.13% | |||
| Total Revenue | 0.31% | -65.13% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 0.31% | -65.13% | |||
| SG&A Expenses | 0.32% | -6.44% | |||
| Depreciation & Amortization | 0.29% | -2.13% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.32% | 8.67% | |||
| Operating Income | -0.32% | -66.60% | |||
| Income Before Tax | -0.32% | -76.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.32% | -76.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.32% | -76.57% | |||
| EBIT | -0.32% | -66.60% | |||
| EBITDA | -0.32% | -68.43% | |||
| EPS Basic | 0.00% | -71.43% | |||
| Normalized Basic EPS | 0.00% | -75.00% | |||
| EPS Diluted | 0.00% | -71.43% | |||
| Normalized Diluted EPS | 0.00% | -75.00% | |||
| Average Basic Shares Outstanding | 0.00% | 3.62% | |||
| Average Diluted Shares Outstanding | 0.00% | 3.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||